Naglazyme
ASB-008
Approved small_molecule completed
Quick answer
Naglazyme for Mucopolysaccharidosis VI is a Approved program (small_molecule) at BioMarin International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Mucopolysaccharidosis VI
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed